Feedback
Disopyramide, Serum or Plasma
2011632
Ordering Recommendation

Optimize drug therapy and monitor patient adherence.

Mnemonic
DISOP
Methodology
Quantitative Enyzme Multiplied Immunoassay Technique
Performed
Tue, Fri
Reported
1-5 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Serum Pre-dose (Trough) Draw - At a Steady State Concentration Serum or Plasma Pre-dose (Trough) Draw - At a Steady State Concentration in Plain Red, Lavender (K2EDTA), Lavender (K3EDTA), or Pink (K2EDTA). 
Specimen Preparation
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
Whole blood. Gel Separator Tubes, Light Blue (Sodium Citrate), or Yellow (SPS or ACD Solution). 
Remarks
Please indicate in the supplied fields:
1.  Dose - List drug amount and include the units of measure
2.  Route - List the route of administration (IV, oral, etc.)
3.  Dose Frequency - Indicate how often the dose is administered (per day, per week, as needed, etc.)
4.  Type of Draw - Indicate the type of blood draw (Peak, Trough, Random, etc.) 
Stability
Ambient: 4 days; Refrigerated: 1 week; Frozen: 2 months 
Reference Interval
Effective November 16, 2015
Therapeutic Range:2.0-6.0 µg/mL
Toxic:Greater than 6.0 µg/mL

Interpretive Data
The therapeutic range is based on serum pre-dose (trough) draw at steady-state concentration. Toxic concentrations may cause dry mouth, hypotension and cardiac abnormalities.

Components
Component Test Code*Component Chart NameLOINC
2011633Disopyramide Dose
2011634Disopyramide Dose Frequency
2011635Disopyramide Route
2011636Disopyramide Type of Draw
2011637Disopyramide, Ser/Pla3576-6
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • disopyramide phosphate
  • Norpace
  • Norpace CR
  • Rythmodan